Informed Consent Process Trips Up Many Clinical Registries – Consultant
This article was originally published in The Gray Sheet
Underestimating the importance of the patient informed consent process is a common and costly mistake made by sponsors of medical device registries, according to Jeremy Tinkler, director of regulatory affairs at consulting firm MedPass International
You may also be interested in...
After adding new language on reprocessed devices, toxic substances and software, the European Parliament overwhelmingly approved a revision of the European Union's Medical Device Directives on March 29
Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.